Two PDA Leaders Recognized as Most Influential People in Drug Development and Manufacture in 2016

BETHESDA, Md., May 10, 2016 /PRNewswire-USNewswire/ -- The Parenteral Drug Association, Inc. (PDA) is pleased to announce that its current volunteer Chair Martin Van Trieste (Amgen) and one of its past chairs, James Agalloco, have been recognized by The Medicine Maker among the "top 100 most influential people in the world of drug development and manufacture."

Van Trieste appears on the list at number thirteen and Agalloco at twenty one, keeping august company with the likes of pharmaceutical CEO's, university professors and renowned researchers, among whom are four Nobel Prize winners.

Van Trieste, who is Sr. VP of Quality at Amgen, was praised for his "quality leadership in biologics" and his record for "advancing quality assurance and helping to ensure a more reliable supply of high-quality medicines." About Agalloco, the publication noted his affiliation with PDA and his prolific writings on the topics of sterilization, aseptic processing and process validation.

The complete list is available at The Medicine Maker. 

About PDA – Connecting People, Science and Regulation®

The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its 10,000 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.

Media Inquiries: Walt Morris, 301-656-5900, x. 148; [email protected]

Logo - http://photos.prnewswire.com/prnh/20130226/DC66667LOGO

SOURCE Parenteral Drug Association

Related Links

http://www.pda.org